#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16692	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2068	800.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1392	1392	C	1020	C	923	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30428	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3433	882.8	0	.	n	.	0	T695C	SNP	695	695	T	958	958	C	940	C,T	858,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30428	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3433	882.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1600	1600	A	1029	A	935	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30428	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3433	882.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2234	2234	C	998	C,T,G	897,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30428	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3433	882.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2308	2308	A	994	A	913	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30428	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3433	882.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2860	2860	C	976	C	885	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	30428	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3433	882.8	0	HET	.	.	.	A790G	.	790	790	A	1053	1053	A	891	A,G	635,172	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2240	folP	855	855	100.0	folP.l15.c4.ctg.1	1508	147.5	1	SNP	p	R229S	0	.	.	685	687	CGC	1063	1065	CGC	221;226;225	C;G;C	205;210;210	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5982	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3475	171.9	1	SNP	p	S91F	0	.	.	271	273	TCC	651	653	TCC	211;212;208	T;C;C	188;191;188	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5982	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3475	171.9	1	SNP	p	D95N	0	.	.	283	285	GAC	663	665	GAC	202;205;205	G;A;C	184;186;188	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5982	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3475	171.9	1	SNP	p	D95G	0	.	.	283	285	GAC	663	665	GAC	202;205;205	G;A;C	184;186;188	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	27	1818	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1182	152.9	1	SNP	p	G45D	1	.	.	133	135	GAC	437	439	GAC	247;247;245	G;A;C	228;222;228	mtrR.WHO_W_01449:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1066	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	951	111.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5880	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2998	195.6	1	SNP	p	D86N	0	.	.	256	258	GAC	595	597	GAC	251;251;255	G;A;C	229;231;232	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5880	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2998	195.6	1	SNP	p	S88P	0	.	.	262	264	TCC	601	603	TCC	255;254;257	T;C,G;C	231;231,1;233	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4788	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2683	178.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1538	1540	GGC	229;227;225	G;G;C	211;210;208	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	0	.	p	.	0	P552L	NONSYN	1654	1656	CCG	1997	1999	CTG	194;195;194	C,G;T,C;G	144,8;132,2;143	.	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1274	1276	GCA	246;244;243	G;C;A,C	228;226;224,1	penA.43.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1277	1279	ATC	241;238;241	A;T;C	221;220;224	penA.43.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1289	1291	GTG	241;241;240	G;T;G	221;216;219	penA.43.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1289	1291	GTG	241;241;240	G;T;G	221;216;219	penA.43.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1793	1795	ACC	242;243;243	A;C;C	214;220;221	penA.43.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1847	1849	GTG	232;226;225	G;T,G;G	202;173,2;196	penA.43.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1847	1849	GTG	232;226;225	G;T,G;G	202;173,2;196	penA.43.002:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1970	1972	GGC	194;196;195	G;G;C	174;173;174	penA.43.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	4430	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2415	182.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1979	1981	GGC	190;188;187	G;G;C	167;167;169	penA.43.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6250	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3086	201.8	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1626	1628	CCG	198;200;201	C;C;G,T	177;178;175,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2558	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1659	153.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	295	297	GGC	179;178;175	G,A;G;C	164,2;162;160	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2558	porA	1146	1146	99.83	porA.l15.c17.ctg.1	1659	153.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	477	477	C	176	C	155	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	S271T	NONSYN	811	813	TCG	106	108	ACT	76;73;71	A;C;T	67;66;64	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	Y273N	NONSYN	817	819	TAT	112	114	AAT	70;65;58	A;A;T	61;57;52	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	115	117	AGT	58;58;57	A;G;T	52;52;51	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	N277H	NONSYN	829	831	AAC	124	126	CAC	59;59;60	C;A;C	52;53;52	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	R307E	NONSYN	919	921	AGA	214	216	GAA	16;16;17	G;A;A	16;16;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	226	228	GCA	15;15;15	G;C;A	15;15;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	E312D	NONSYN	934	936	GAA	229	231	GAC	15;15;14	G;A;C	15;15;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	235	237	ATC	13;13;13	A;T;C	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	241	243	TCG	13;12;12	T;C;G	13;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	247	249	GCC	12;12;12	G;C;C	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	250	252	AGC	12;12;10	A;G;C	12;12;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	253	255	GCC	10;10;10	G;C;C	10;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	378	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	284	41.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	259	261	GTT	9;9;8	G;T;T	9;9;8	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3306	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1509	217.8	0	.	p	.	0	G120N	NONSYN	358	360	GGC	660	662	AAC	277;281;281	A;A;C	256;261;258	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3306	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1509	217.8	0	.	p	.	0	Y216_S217del	DEL	646	646	T	948	948	T	289	T	259	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3306	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1509	217.8	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1176	1178	AAT	285;282;275	A;A;T	262;258;255	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3306	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1509	217.8	1	SNP	p	D121N	0	.	.	361	363	GAC	663	665	GAC	285;286;284	G;A;C	263;263;262	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3306	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1509	217.8	1	SNP	p	A121D	1	.	.	361	363	GAC	663	665	GAC	285;286;284	G;A;C	263;263;262	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11854	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4753	248.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1248	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1051	118.6	1	SNP	p	V57M	1	.	.	169	171	ATG	533	535	ATG	277;278;274	A,G;T;G	246,1;249;244	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
